Houston-based Topl has joined forces with an Austin company to safely track COVID-19 test kit results. Photo via Getty Images

A Houston-based blockchain network developer has established a partnership with an Austin-based developer to track and trace COVID-19 test kits.

Topl and Media Sourcery Inc. announced this week that they are teaming up to jointly develop and launch various blockchain-powered platforms. The first of the projects will use Topl's impact-focused blockchain with MSI's workflow automation and security tools in a health care application involved in tracking test kits for COVID-19.

With a goal of increasing transparency while maintaining security, Topl and MSI's test kit tracking process can provide results to those who need them while remaining HIPAA compliant and secure.

"Identity solutions are extremely important to the blockchain community," says Kim Raath, CEO of Topl, in a press release. "Blockchain technology is uniquely suited to prove identity and make authorizations more secure. This is something that will be particularly useful in healthcare applications, as we can be guaranteed that patient data and medical information remains private, secured, and tracked, as opposed to some current methods that are not able match patient identities with patient procedures and treatments."

Two health care companies are already involved in the project. California-based Achieve Health Management will be the distributor of the kits and Osang Healthcare, the first South Korean firm to receive FDA approval for COVID-19 test kit distribution in the United States, will be the test kit manufacturer.

"The transparency of having a shared public ledger for the transport, storage, and handling events of the GeneFinder COVID-19 Plus RealAmp Tests will provide unprecedented assurance to our labs, customers and test populations," says Stacy Chick, chief commercial officer for Achieve Health Management, in the release. "This application will also help ensure our end-to-end process provides proper test kit handling and storage in temperature-controlled environments for optimal test performance".

Topl and MSI have plans for other COVID-related projects, including tracking vaccines as they continue to be developed and eventually distributed.

"The technology under our non-repudiation patent provides a layer of certified trust," says Larry Ketchersid, CEO of MSI, in the release. "Combining that solution with the immutability and shared public ledger provided by the Topl blockchain-as-a-service solution will give our customers the highest level of transparency, visibility and trust."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas lands top 10 spot in new future of tech study

report

Texas is among the top 10 states making the biggest investments in digital innovation, according to a new study.

The study, conducted by web-hosting company Hostinger, puts Texas in eighth place among the states when it comes to these key metrics:

  • Financial impact of the digital economy
  • Amount of venture capital and grants received by digital startups
  • Number of government-run tech hubs
  • Presence of top-rated business incubators

“To many, the Texas story is one of oil magnates and real estate tycoons. But in recent decades, the state has emerged as an innovation and high-tech hub,” according to a report from the Federal Reserve Bank of Dallas.

On a scale of 1 to 100, Texas received a score of 79. California nabbed the top spot with a score of 100. Appearing behind California and ahead of Texas in the ranking are:

  • No. 2: New York
  • No. 3: Washington
  • No. 4: Illinois
  • No. 5: Massachusetts
  • No. 6: Missouri
  • No. 7: Wisconsin

In terms of ranking factors, Texas benefited the most from landing at No. 2 among the states for its impact on the digital economy. The study pegged Texas’ digital economic impact at $141.7 billion, well below California’s impact of $492.8 billion.

Hostinger relied primarily on government data on 31 states to come up with the ranking. “The research provides a detailed ranking based on a composite score that reflects each state's overall investment and capacity for digital innovation,” the company says.

More than 30,000 businesses in Texas participate in the digital economy, according to the Computer & Communications Industry Association (CCIA). Those businesses employ more than 633,000 people and account for over six percent of the state’s GDP, a key measure of economic strength.

“As technology companies face increasing scrutiny through state and national legislation and litigation, it’s crucial to recognize the significant positive impacts of the digital economy that resonate across the United States,” says the CCIA.

TMC names 2025 cohort of cancer treatment innovators

ready to grow

Texas Medical Center Innovation has named more than 50 health care innovators to the fifth cohort of its Accelerator for Cancer Therapeutics (ACT).

The group specializes in immunotherapy, precision drug discovery, monoclonal antibodies, and diagnostic and therapeutic technologies, according to a statement from TMC.

During the nine-month ACT program, participants will enjoy access to a network of mentors, grant-writing support, chemistry resources, and the entrepreneur-in-residence program. The program is designed to equip participants with the ability to secure investments, develop partnerships, and advance the commercialization of cancer therapeutics in Texas.

“With over 35 million new cancer cases predicted by 2050, the urgency to develop safer, more effective, and personalized treatments cannot be overstated,” Tom Luby, chief innovation officer at Texas Medical Center, said in a news release.

Members of the new cohort are:

  • Alexandre Reuben, Kunal Rai, Dr. Cassian Yee, Dr. Wantong Yao, Dr. Haoqiang Ying, Xiling Shen, and Zhao Chen, all of the University of Texas MD Anderson Cancer Center
  • Dr. Andre Catic and Dr. Martin M. Matzuk, both of the Baylor College of Medicine
  • Cynthia Hu and Zhiqiang An, both of UTHealth Houston
  • Christopher Powala, Aaron Sato, and Mark de Souza, all of ARespo Biopharma
  • Daniel Romo, Dr. Susan Bates, and Ken Hull, all of Baylor University
  • Eugene Sa & Minseok Kim, both of CTCELLS
  • Gomika Udugamasooriya and Nathaniel Dawkins, both of the University of Houston
  • Dr. Hector Alila of Remunity Therapeutics
  • Iosif Gershteyn and Victor Goldmacher, both of ImmuVia
  • João Seixas, Pedro Cal, and Gonçalo Bernardes, all of TargTex
  • Ken Hsu and Yelena Wetherill, both of the University of Texas at Austin
  • Luis Martin and Dr. Alberto Ocaña, both of C-Therapeutics
  • Dr. Lynda Chin, Dr. Keith Flaherty, Dr. Padmanee Sharma, James Allison, and Ronan O’Hagan, all of Project Crest/Apricity Health
  • Michael Coleman and Shaker Reddy, both of Metaclipse Therapeutics
  • Robert Skiff and Norman Packard, both of 3582.ai
  • Rolf Brekken, Uttam Tambar, Ping Mu, Su Deng, Melanie Rodriguez, and Alexander Busse, all of UT Southwestern Medical Center
  • Ryan Swoboda and Maria Teresa Sabrina Bertilaccio, both of NAVAN Technologies
  • Shu-Hsia Chen and Ping-Ying Pan, both of Houston Methodist
  • Thomas Kim, Philipp Mews, and Eyal Gottlieb, all of ReEngage Therapeutics
The ACT launched in 2021 and has had 77 researchers and companies participate. The group has collectively secured more than $202 million in funding from the NIH, CPRIT and venture capital, according to TMC.